The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in myelodysplastic syndromes and its prognostic significance. Eur J Histochem [Internet]. 2009 Jun. 29 [cited 2025 May 31];49(1):27-32. Available from: https://www.ejh.it/ejh/article/view/923